61 filings
6-K
MYNZ
Mainz Biomed N.V.
24 Apr 24
Announcement of Annual General Meeting of
6:08am
6-K
MYNZ
Mainz Biomed N.V.
19 Apr 24
Report of Foreign Private Issuer
6:05am
20-F
2023 FY
MYNZ
Mainz Biomed N.V.
Annual report (foreign)
8 Apr 24
7:52pm
6-K
MYNZ
Mainz Biomed N.V.
23 Feb 24
Report of Foreign Private Issuer
4:42pm
6-K
MYNZ
Mainz Biomed N.V.
16 Nov 23
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:12am
6-K
rkephj52ij6s0k vqr
15 Nov 23
Report of Foreign Private Issuer
9:21am
424B5
raq60chr4lnlggmjei7
14 Nov 23
Prospectus supplement for primary offering
4:16pm
6-K
jm14i53 z6m6xif
13 Nov 23
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
4:05pm
424B5
efej6l7a6axkm6mr
26 Sep 23
Prospectus supplement for primary offering
5:00pm
6-K
fhjk6c vywjxh769htn
13 Sep 23
Report of Foreign Private Issuer
8:30am
6-K
9417f ozdytr5p
15 Aug 23
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:23am
S-8
uvgnzmh
11 Jul 23
Registration of securities for employees
4:35pm
D
skakpc
11 Jul 23
$50.00 mm in equity / debt / options / securities to be acquired, sold $5.50 mm, 1 investor
4:15pm
6-K
vionm
28 Jun 23
Report of Foreign Private Issuer
4:31pm
424B5
ebzsq2s m0hq0
28 Jun 23
Prospectus supplement for primary offering
4:30pm
6-K
zg8hl9e6uuxe2
19 May 23
Report of Foreign Private Issuer
4:59pm
6-K
nbvx lh26o
16 May 23
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:56am
6-K
7sb12
21 Feb 23
Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
8:01am
6-K
qvlfp004 6r1f9n
20 Jan 23
Report of Foreign Private Issuer
4:01pm